FDA Panel Backs Novavax's COVID-19 Vaccine
A U.S. Food and Drug Administration advisory panel on Tuesday voted overwhelmingly to approve emergency use of Novavax Inc.'s COVID-19 vaccine for adults, moving the country closer to offering a new...To view the full article, register now.
Already a subscriber? Click here to view full article